Canadian neurosurgeons seek six patients for Musk's Neuralink brain study TORONTO - Canadian neurosurgeons in partnership with Elon Musk's Neuralink have regulatory approval to recruit six patients with paralysis willing to have a thousand electrode contacts in their brains. The trial, called Can-Prime has started recruiting patients for a study that will test the safety and efficacy of a device that allows people to move cursors with their minds, a surgeon leading the trial said. LINK
Neuralink gets okay for its first international trial Elon Musk's brain-computer interface (BCI) company Neuralink has been given the green light to test its device in tetraplegic patients in Canada – the first international trial of the technology. The CAN-PRIME study will run alongside Neuralink's recently initiated PRIME study in the US and will test the safety and functionality of its N1 implant in people who have difficulty moving their arms and legs to see if it can act as a hands-free interface between the brain and electronic devices, allowing them to be controlled with thoughts alone. LINK
